龙沙集团（场外交易代码：LZAGY）交易量激增——现在是买入时机吗？- MarketBeat
Lonza Group (OTCMKTS:LZAGY) Sees Large Volume Increase - Time to Buy? - MarketBeat
生命科学资讯
生物技术与制药领域的最新动态
行业圆桌：小分子原料药：2026年展望——DCAT价值链洞见
Industry Roundtable: Small-Molecule APIs: What’s in Store for 2026? - DCAT Value Chain Insights
龙沙集团（场外交易代码：LZAGY）股价下跌1.8%——未来走势如何？——MarketBeat
Lonza Group (OTCMKTS:LZAGY) Trading Down 1.8% - What's Next? - MarketBeat
一种更智能、更快速的凝胶电泳方法
A Smarter, Faster Way to Perform Gel Electrophoresis - the-scientist.com
龙沙集团：默默驱动下一波生物科技浪潮的隐形引擎 - 特别报道
Lonza Group AG: The Quiet Engine Powering the Next Wave of Biotech - AD HOC NEWS
龙沙集团（VTX:LONN）股价飙升3.4%；持有52%股份的个人投资者与机构共同获利——Simplywall.st报道。
Lonza Group AG (VTX:LONN) surges 3.4%; individual investors who own 52% shares profited along with institutions - simplywall.st
龙沙集团（VTX:LONN）股价飙升3.4%；持有52%股份的个人投资者与机构同享收益——Simplywall.st报道
Lonza Group AG (VTX:LONN) surges 3.4%; individual investors who own 52% shares profited along with institutions - simplywall.st
豌豆种植持续至2026年，朗盛与高尔夫球场项目齐头并进——Seacoastonline.com
Pease growth carries into 2026 with projects at Lonza, golf course - Seacoastonline.com
龙沙集团调整两名高管职务 - MSN
Lonza shuffles two executive roles - MSN
龙沙集团调整两名高管职务 - MSN
Lonza shuffles two executive roles - MSN
龙沙集团（VTX:LONN）的内在价值可能比其股价低26% - 雅虎财经
Lonza Group AG's (VTX:LONN) Intrinsic Value Is Potentially 26% Below Its Share Price - Yahoo Finance
埃文斯加时赛建功，橡树岭队夺得大都会联盟男子篮球冠军——奥兰多哨兵报
Evans in OT, Oak Ridge claim Metro Conference boys basketball titles - Orlando Sentinel
Synaffix与Sidewinder携手推进新一代双特异性ADC研发——基因工程与生物技术新闻
Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News
Synaffix与Sidewinder达成协议，共同推进新一代双特异性抗体药物偶联物研发——基因工程与生物技术新闻
Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News
龙沙Synaffix与Sidewinder合作开发抗体药物偶联物 - 医药快讯
Lonza’s Synaffix and Sidewinder collaborate on ADCs - The Pharma Letter
龙沙Synaffix与Sidewinder合作开发ADC药物 - 医药通讯
Lonza’s Synaffix and Sidewinder collaborate on ADCs - The Pharma Letter
Lonza旗下Synaffix与Sidewinder合作开发双特异性抗体药物偶联物
Lonza’s Synaffix and Sidewinder partner on bispecific ADCs By Investing.com - Investing.com Canada
龙沙集团Synaffix与Sidewinder合作开发双特异性抗体药物偶联物 - Investing.com
Lonza’s Synaffix and Sidewinder partner on bispecific ADCs - Investing.com
龙沙集团Synaffix与Sidewinder Therapeutics签署多靶点许可协议，共同推进下一代双特异性ADC药物研发
Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs - Yahoo Finance
龙沙集团股票：悄然反弹，投资者谨慎乐观，权衡生物科技新篇章——特别报道
Lonza Group AG stock: Quiet rebound, cautious optimism as investors weigh biotech’s next chapter - AD HOC NEWS